GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Share News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Stocks End Lower On Chinese And Italian Woes

Mon, 08th Oct 2018 17:07

LONDON (Alliance News) - Stocks closed lower Monday on the actions of the Chinese and Italian governments, as the pound continued its fall on news from 10 Downing Street there remains "big issues" in the way of any potential Brexit deal."Equity markets are in the red as we approach the close of trading as concerns about China and Italy, prompted traders to dump equities. The Chinese central bank lowered the reserve required ratio again - the fourth time this year," said David Madden, market analyst at CMC Markets UK. Madden continued: "The move is viewed as a sign of weakness and dealers are fearful the Chinese economy is cooling at a quick rate and needs support. Beijing and Washington DC are still locked in a trade spat, and trimming the reserve required ratio could be construed as an indication that they are in it for the long haul."The FTSE 100 index closed down 1.2%, or 85.21 points at 7,233.33. The FTSE 250 ended 1.4% lower, or 271.95 points, at 19,646.08, and the AIM All-Share closed down 2.7%, or 29.13 points, at 1,040.00.The Cboe UK 100 ended down 1.2% at 12,283.95, the Cboe 250 closed down 1.3% at 17,847.18, and the Cboe Small Companies ended 0.5% lower at 11,959.56.The pound was quoted at USD1.3061 at the London equities close, compared to USD1.3096 at the same time on Friday. Downing Street has played down expectations of agreement on Britain's withdrawal from the EU at a crunch summit next week, warning that "big issues" remain to be resolved.Theresa May's official spokesman said further concessions were needed from the EU side, and warned that no withdrawal agreement could be sealed without a "precise" declaration about the post-Brexit relationship.The comments appeared to pour cold water on upbeat assessments on the prospects of a deal made by senior EU figures over recent days.Just over a week remains before the October 18 summit in Brussels which was initially pencilled in as the deadline for agreement on withdrawal.But Downing Street would say only that the UK was working for a deal "this autumn", fuelling speculation that a special summit in November will be needed to hammer out agreement on issues including the status of the Irish border.Technical talks are continuing at official level in Brussels this week, but no visit by Brexit Secretary Dominic Raab has been announced, and Downing Street would say only that new proposals on the border issue would be released "in due course".In London equities, one of the the biggest fallers in the FTSE 100 was Halma, down 4.7% after Shore Capital downgraded the hazard detection firm to Hold from Buy.Another of Monday's losers, Vodafone, was also lower after a broker downgrade. Jefferies cut its rating on the telecommunications stock to Hold from Buy, leaving Vodafone shares trading down 3.5%.Standard Life Aberdeen ended the day down 2.8% on news Schroders, down 0.8%, and Lloyds Banking, down 1.3%, are in discussions "with a view to working closely together in parts of the wealth sector".Sky News earlier had reported that Lloyds is to inject its GBP13 billion wealth management arm into a new joint venture with Schroders. The deal will see Lloyds owning 50.1% of the new joint venture, with Schroders owning the rest, Sky said.It will be part of a three-pronged tie-up between the companies, with Schroders taking on a GBP109 billion investment management contract from Lloyds-owned Scottish Widows, according to Sky. The contract is currently held by Standard Life Aberdeen but has been terminated by Lloyds over competition worries. Meanwhile at the other end of the blue chip index, Segro gained 1.5% after Goldman Sachs raised the property investor and developer to Buy from Neutral.Catering and support services firm Compass closed up 0.9% after it sold Vision Security for GBP14 million in cash to outsourcing and services company Mitie.Vision Security is a security services provider which offers security systems, as well as manned guarding and key holding services.The acquisition is expected to be completed by the end of OctoberInsurers were among those falling in the FTSE 250 following a third quarter warning from Lancashire Holdings, the stock down ending the day down 5.9%.The reinsurer said it expects to post a negative return on equity for the third quarter of 2018 due to losses from a number of recent natural disasters including Hurricane Florence and typhoons Jebi, Mangkhut and Trami.Lancashire estimates losses from recent natural catastrophe events to be in a range of USD25 million to USD45 million. It also expects to record a USD30 million net loss from its marine portfolio.Other insurers were hit in a negative read-across following the update, with Hiscox down 2.6% and Beazley down 4.2%.IP Group ended down 5.4% after reporting that its portfolio company, Diurnal, did not see Chronocort meet its primary objective in a phase three trial.Chronocort is intended to treat congenital adrenal hyperplasia, an orphan condition in which patients have a block in cortisol production. The goal of the phase three trial was to "demonstrate the superiority of Chronocort to conventional therapy", a goal which was not met as both Chronocort and conventional therapy proved equivalent.Shares in Diurnal were a steep 60% lower at close.The euro stood at USD1.1476 at the European equities close, against USD1.1509 the prior day.Friday's sell-off continued in mainland Europe with the CAC 40 in Paris ending down 1.1%, while the DAX 30 in Frankfurt ended 1.4% lower.David Madden said: "The yield on the 10-year Italian government bond hit its highest level in over four years as the Rome administration is set to be on a collision course with Brussels over the budget deficit. Matteo Salvini, the joint deputy prime minister, confirmed the country will not be dropping the euro, but he asked that the ratings agencies be fair when assessing Italy's credit worthiness." "Investors are nervous about the prospect of an already very indebted nation potentially clocking up even more debt."Germany's industrial production declined unexpectedly in August on a notable weakness in construction, suggesting that the economy lost some momentum in the third quarter.Data from Destatis showed that industrial output slid 0.3% from July, confounding expectations for an increase of 0.5%. This was the third consecutive decline in output. Production had decreased 1.3% in July.On a yearly basis, industrial production logged a fall of 0.1% in August, in contrast to the expected growth of 0.1% and a 1.5% increase seen in July.The fall in industrial output was much weaker than expected and suggests that the economy is very unlikely to match second quarter's 0.5% expansion in the third quarter, Jennifer McKeown, an economist at Capital Economics, said.But Germany will continue to be one of Eurozone's strongest performers, the economist noted.Elsewhere, a survey from the think tank Sentix showed that despite the negative discussions about the automotive industry and the question marks over the continued existence of the current government coalition, the German economic data remain stable.The investor confidence index for Germany rose to 20.0 in October from 18.1 in September.In UK data on Monday, a quarterly survey from the British Chambers of Commerce said the UK economy is stuck in a rut due to Brexit uncertainties.The balance of manufacturing firms reporting a fall in domestic sales rose to 24, while that of services firms fell to 23. Domestic orders for manufacturing declined, while services reported improved domestic orders.The lobby warned that the slowdown in exports in the manufacturing sector, and many services firms seemingly giving up trying to hire new staff, should be cause for concern."There has never been a more important time for the government to bolster business investment, competitiveness and productivity, in the face of significant Brexit headwinds," Adam Marshall, Director General of the BCC said.Stocks in New York were heading south at the London equities close on rising fears of more hikes from the US central bank as the yield on the 10-year hit a seven year high on Friday.The DJIA was 0.2% lower, the S&P 500 index down 0.2% and the Nasdaq Composite 0.5% lower.Chinese Foreign Minister Wang Yi gave US Secretary of State Mike Pompeo a cool reception in Beijing, as he warned of "conflict and confrontation" between the two world powers.Wang told Pompeo the US has escalated trade frictions between the two economies, and undermined China's interests on issues such as Taiwan and other domestic and foreign policies, the state-owned China Daily reported."We demand the US stop the unwarranted accusations and wrongdoings against China immediately," Wang said, warning against the US "taking a wrong approach of conflict and confrontation."Pompeo is on an East Asia tour focused on deciding the next steps in North Korea's denuclearization.Brent oil was quoted at USD83.49 a barrel at the equities close from USD84.69 at the same time the prior day. Gold was quoted at USD1,185.30 an ounce at the London equities close against USDUSD1,201.70 on Friday.The economic calendar on Tuesday has British Retail Consortium Retail Sales for September at 0001 BST, UK Financial Policy Committee statement at 0930 BST, German August imports and exports at 0700 BST, and US Treasury 52-week, 4-week, 3-month and 6-month bill auctions. The UK corporate calendar has full year production from Centamin, trading statements from Greggs, YouGov, Ceres Power and half year results from Lidco.
More News
2 Dec 2019 13:19

Diurnal submits application for 'Alkindi Sprinkle' to US FDA

(Sharecast News) - Specialty pharmaceutical company Diurnal Group has submitted a 'New Drug Application' (NDA) to the US Food and Drug Administration (FDA), for the regulatory approval of 'Alkindi Sprinkle', or hydrocortisone granules in capsules for opening, as a replacement therapy of adrenal insufficiency in infants, children and adolescents in the US, it announced on Monday.

Read more
21 Nov 2019 11:36

Diurnal Primary Focus Remains On Progressing Flagship Products

Diurnal Primary Focus Remains On Progressing Flagship Products

Read more
20 Nov 2019 11:36

Diurnal To Explore Further Tests As Testosterone Treatment Does Well

Diurnal To Explore Further Tests As Testosterone Treatment Does Well

Read more
24 Sep 2019 11:21

Diurnal Loss Narrows On Research Expenses And Alkindi Launch

Diurnal Loss Narrows On Research Expenses And Alkindi Launch

Read more
14 Jun 2019 14:26

Diurnal Shareholders Approve Placing, Open Offer Worth GBP6 Million (ALLISS)

(Alliance News) - Pharmaceutical firm Diurnal Group PLC's shareholders on Friday approved its GBP5.9 million fundraise completed earlier in the day.Diurnal, which focuses on patients or

Read more
28 May 2019 13:32

Diurnal Group launches placing and open offer to fund drug development

(Sharecast News) - Specialty pharmaceutical company Diurnal Group announced a conditional placing of new ordinary shares in the company and the launch of an open offer on Tuesday, in order to raise funds to progress the development and commercialisation of its products.

Read more
28 May 2019 10:49

Diurnal Raises GBP5 Million Via Placing; Plans GBP1 Million Open Offer (ALLISS)

LONDON (Alliance News) - Diurnal Group PLC said Tuesday it has raised around GBP5.4 million via a 20.6 million share placing priced at 26 pence per share and announced an open offer to raise up to

Read more
10 May 2019 09:36

Polar Capital Global Healthcare Lags Behind Benchmark In First Half

LONDON (Alliance News) - Polar Capital Global Healthcare Trust PLC said on Friday it lagged against its benchmark for the first half of its financial year, as the healthcare trust underperformed a

Read more
24 Apr 2019 15:50

Diurnal gets orphan drug designation for Alkindi in Australia

(Sharecast News) - Specialty pharmaceutical company Diurnal Group announced on Wednesday that its 'Alkindi' product - hydrocortisone granules in capsules for opening - had been granted orphan drug designation in Australia by the Therapeutic Goods Administration, for the indication 'replacement therapy of adrenal insufficiency (AI) in infants, children and adolescents from birth to 18 years old'.

Read more
24 Apr 2019 10:44

Diurnal Gets Orphan Drug Designation For Alkindi In Australia

LONDON (Alliance News) - Diurnal Group PLC on Wednesday said its adrenal insufficiency drug Alkindi has been granted a second patent and orphan drug designation in Australia.Shares in were

Read more
28 Mar 2019 08:35

Diurnal soars after securing Nordic distribution deal

(Sharecast News) - Diurnal's shares leapt on Thursday despite a widened interim loss as the company landed a marketing and distribution deal for its Alkindi treatment in Scandinavia.

Read more
21 Mar 2019 16:11

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 22 March Sanne GroupFull Year ResultsSmiths GroupHalf Year BootFull Year

Read more
20 Mar 2019 10:33

Diurnal Group upbeat following FDA meeting over 'Alkindi'

(Sharecast News) - Specialty pharmaceutical company Diurnal Group announced on Wednesday that, following a "positive" meeting with the US Food and Drug Administration (FDA), it intended to submit a new drug application (NDA) for 'Alkindi' (hydrocortisone granules in capsules for opening) in the fourth quarter of 2019 as previously planned, with final acceptance of the filing by the FDA expected in 2020.

Read more
25 Feb 2019 10:39

Diurnal expecting Israel launch of 'Alkindi' next year

(Sharecast News) - Specialty pharmaceutical company Diurnal Group announced on Monday that its marketing and distribution partner, Medison Pharma has successfully submitted a market authorisation application (MAA) for its 'Alkindi' (hydrocortisone granules in capsules for opening) product to the Ministry of Health in Israel.

Read more
10 Jan 2019 12:35

Diurnal Granted US Patent But Unsure Why Share Price Has Tripled

LONDON (Alliance News) - Diurnal Group PLC said on Thursday that, aside from the granting of a patent, it is unsure as to why its share price has tripled.Shares were 188% higher on Thursday

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.